Tudor Investment Corp’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-475,004
Closed -$71.8M 2180
2022
Q3
$71.8M Buy
475,004
+147,269
+45% +$22.3M 1.55% 3
2022
Q2
$47.8M Buy
+327,735
New +$47.8M 1.25% 3
2021
Q4
Sell
-3,911
Closed -$543K 2284
2021
Q3
$543K Buy
+3,911
New +$543K 0.01% 1105
2021
Q2
Sell
-92,658
Closed -$6.33M 2114
2021
Q1
$6.33M Buy
92,658
+88,521
+2,140% +$6.05M 0.13% 127
2020
Q4
$355K Sell
4,137
-276
-6% -$23.7K 0.01% 1053
2020
Q3
$287K Buy
+4,413
New +$287K 0.01% 993
2020
Q2
Sell
-19,004
Closed -$647K 1537
2020
Q1
$647K Sell
19,004
-16,810
-47% -$572K 0.06% 384
2019
Q4
$1.95M Buy
35,814
+21,216
+145% +$1.16M 0.09% 285
2019
Q3
$609K Sell
14,598
-13,496
-48% -$563K 0.02% 644
2019
Q2
$1.23M Buy
+28,094
New +$1.23M 0.04% 460